RPIDRapid Micro Biosystems, Inc.
Earnings
When Rapid Micro Biosystems, Inc. reports, what it reported each quarter, and how the stock took the results.
26 quarters. Mar 31, 2020 to Jun 30, 2026. USD.
Next results · Q3 2026Released
Yesterday, during market hours
Mon, Nov 16, 20261 day ago
The results are out. The figures reach the desk with the 10-Q.
- Quarter
- Q3 2026 · Ended Sep 30, 2026
- 10-Q window
- Oct 30 – Nov 13
Read against Q3 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- $7.84M
- Revenue, change from a year earlier: Q2 2026 +10.9%, Q1 2026 +11.1%, Q4 2025 +37.3%, Q3 2025 +3.1%
- Net income
- -$11.51M
- Net income, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m, Q3 2025 n/m
- EPS
- -$0.26
- EPS, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m, Q2 2025 n/m
Latest results
- Revenue
- $8.05M
- +10.9%
- Net income
- -$12.92M
- N/M
- EPS
- -$0.27
- N/M
- Revenue
- $8.00M
- +11.1%
- Net income
- -$14.28M
- N/M
- EPS
- -$0.31
- N/M
- Revenue
- $11.28M
- +37.3%
- Net income
- -$12.50M
- N/M
- EPS
- —
- —
- Revenue
- $7.84M
- +3.1%
- Net income
- -$11.51M
- N/M
- EPS
- -$0.26
- N/M
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q2 2026 | Jun 30, 2026 | Aug 7, 2026 · pre-market | Aug 7, 2026 | 38 d | 10-Q | $8.05M | +10.9% | -$0.27 | 16.8% | |
| Q1 2026 | Mar 31, 2026 | May 13, 2026 · after-hours | May 15, 2026 | 45 d | 10-Q | $8.00M | +11.1% | -$0.31 | 7.6% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Mar 12, 2026 · pre-market | Mar 12, 2026 | 71 d | 10-K | $11.28M | +37.3% | — | 22.1% | |
| Q3 2025 | Sep 30, 2025 | Nov 7, 2025 · pre-market | Nov 7, 2025 | 38 d | 10-Q | $7.84M | +3.1% | -$0.26 | +9.2% | |
| Q2 2025 | Jun 30, 2025 | Aug 12, 2025 · pre-market | Aug 12, 2025 | 43 d | 10-Q | $7.26M | +9.7% | -$0.27 | 21.2% | |
| Q1 2025 | Mar 31, 2025 | May 9, 2025 · pre-market | May 9, 2025 | 39 d | 10-Q | $7.21M | +28.4% | -$0.26 | +26.5% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Feb 28, 2025 · pre-market | Feb 28, 2025 | 59 d | 10-K | $8.22M | +29.7% | — | 7.9% | |
| Q3 2024 | Sep 30, 2024 | Nov 1, 2024 · pre-market | Nov 7, 2024 | 38 d | 10-Q | $7.60M | +23.7% | -$0.26 | +0.5% | |
| Q2 2024 | Jun 30, 2024 | Aug 2, 2024 · pre-market | Aug 2, 2024 | 33 d | 10-Q | $6.62M | +32.3% | -$0.29 | — | |
| Q1 2024 | Mar 31, 2024 | May 3, 2024 · pre-market | May 3, 2024 | 33 d | 10-Q | $5.61M | +11.4% | -$0.31 | — | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Mar 1, 2024 · pre-market | Mar 1, 2024 | 61 d | 10-K | $6.34M | +44.9% | — | 10.9% | |
| Q3 2023 | Sep 30, 2023 | Nov 3, 2023 · pre-market | Nov 3, 2023 | 34 d | 10-Q | $6.15M | +29.7% | -$0.31 | — | |
| Q2 2023 | Jun 30, 2023 | Aug 4, 2023 · pre-market | Aug 4, 2023 | 35 d | 10-Q | $5.00M | +29.6% | -$0.33 | 7.1% | |
| Q1 2023 | Mar 31, 2023 | May 5, 2023 · pre-market | May 9, 2023 | 39 d | 10-Q | $5.04M | +21.0% | -$0.32 | 6.3% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Mar 3, 2023 · pre-market | Mar 10, 2023 | 69 d | 10-K | $4.37M | −16.0% | — | +15.9% | |
| Q3 2022 | Sep 30, 2022 | Nov 10, 2022 · pre-market | Nov 10, 2022 | 41 d | 10-Q | $4.74M | −31.3% | -$0.38 | +5.4% | |
| Q2 2022 | Jun 30, 2022 | Aug 12, 2022 · pre-market | Aug 12, 2022 | 43 d | 10-Q | $3.86M | −37.0% | -$0.31 | 4.3% | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · pre-market | May 10, 2022 | 40 d | 10-Q | $4.16M | −16.7% | -$0.35 | 7.1% | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | Mar 4, 2022 · pre-market | Mar 24, 2022 | 83 d | 10-K | $5.21M | — | — | 13.4% | |
| Q3 2021 | Sep 30, 2021 | Nov 12, 2021 · pre-market | Nov 15, 2021 | 46 d | 10-Q | $6.90M | +31.5% | -$0.71 | 19.6% | |
| Q2 2021 | Jun 30, 2021 | Aug 26, 2021 · after-hours | Aug 27, 2021 | 58 d | 10-Q | $6.13M | +136.4% | -$20.01 | 6.3% | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | $5.00M | — | -$37.89 | — | |
| FY 2020 | ||||||||||
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | $5.25M | — | -$30.08 | — | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $2.59M | — | -$31.93 | — | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | — | — | — | — | |
Earlier years, FY 2020 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Rapid Micro Biosystems, Inc. · CIK 1380106 · Engraved from SEC EDGAR